Literature DB >> 15955126

The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.

V G Athyros1, V I Bouloukos, A N Pehlivanidis, A A Papageorgiou, S G Dionysopoulou, A N Symeonidis, D I Petridis, M I Kapousouzi, E A Satsoglou, D P Mikhailidis.   

Abstract

BACKGROUND: The Third Report (ATP III) of the National Cholesterol Education Program Expert Panel (NCEP) highlighted the importance of identifying and treating patients with the metabolic syndrome (MetS) to prevent cardiovascular disease (CVD) and progression to diabetes mellitus. Limited information is available about the prevalence of MetS, as defined by the NCEP ATP III, in Europe, especially in Greece.
OBJECTIVE: To estimate the prevalence of the MetS in Greece, The MetS-Greece Study. DESIGN AND PARTICIPANTS: A cross-sectional analysis of a representative sample of Greek adults (4153 participants older than 18 years). One group consisting of military personnel (n = 300) and another one from a Greek Muslim Community (n = 300) were used for comparison. In all, 4753 subjects were included in the final analysis.
RESULTS: All subjects from the general population were Caucasian men (49%) and women (51%), living in urban (n = 2243, 54%), semi-urban (n = 1038, 25%) and rural (n = 872, 21%) areas. The age-standardized prevalence of the MetS was 23.6%[95% confidence interval (CI): 22.4-25.1%]. This was similar in men (24.2%, 95% CI: 22.3-25.2%) and women (22.8%, 95% CI: 21.4-25.0%) (p = 0.3). The prevalence increased with age in both sexes, 4.8% among participants aged 19-29 years and 43% for participants over 70 years old (p for trend < 0.0001). There was a 14.7-fold increase in odds ratio for having MetS in the age group > 70 years old compared with that of 19-29 years old (p < 0.0001) Most of those with MetS had three components of the syndrome (61%), 29% had four and 10% had all five components. Abdominal obesity (82%) and arterial hypertension (78%) were the most common abnormalities in both sexes. The Greek Muslim Community, on a high-saturated fat diet, had the highest prevalence of the MetS (35.2%, 95% CI: 30.4-40.3%), and the military group, with a high physical activity level and a diet 'close' to Mediterranean, had the lowest (9.4%, 95% CI: 6.2-13.1%). According to the 2001 Census, about 2.3 million Greeks may have the MetS.
CONCLUSIONS: These results show that the MetS is highly prevalent in the Greek adult population. This may have major implications for the incidence of CVD. Promoting healthy diets, low caloric intake and physical activity must be urgently undertaken.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955126     DOI: 10.1111/j.1463-1326.2004.00409.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  37 in total

1.  Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study.

Authors:  Selçuk Altın; Tunç Ozan; Selçuk İlhan; Nevin İlhan; Rahmi Onur
Journal:  Turk J Urol       Date:  2015-09

Review 2.  Genetics of metabolic syndrome.

Authors:  Alena Stančáková; Markku Laakso
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

3.  Association between components of metabolic syndrome and prostatic enlargement: An Indian perspective.

Authors:  P R Nandy; Sabyasachi Saha
Journal:  Med J Armed Forces India       Date:  2016-09-05

Review 4.  Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.

Authors:  Ajay Duseja; Shivaram P Singh; Vivek A Saraswat; Subrat K Acharya; Yogesh K Chawla; Subhankar Chowdhury; Radha K Dhiman; Rohinivilasam V Jayakumar; Kaushal Madan; Sri P Misra; Hrudananda Mishra; Sunil K Modi; Arumugam Muruganathan; Banshi Saboo; Rakesh Sahay; Rajesh Upadhyay
Journal:  J Clin Exp Hepatol       Date:  2015-03-06

5.  Combination drug treatment in obese diabetic patients.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Diabetes       Date:  2010-03-15

6.  Adherence to Mediterranean diet and close dietetic supervision increase total dietary antioxidant intake and plasma antioxidant capacity in subjects with abdominal obesity.

Authors:  Anastasia I Kolomvotsou; Loukianos S Rallidis; Konstantinos C Mountzouris; John Lekakis; Antonis Koutelidakis; Stamatis Efstathiou; Maria Nana-Anastasiou; Antonis Zampelas
Journal:  Eur J Nutr       Date:  2012-01-12       Impact factor: 5.614

7.  Metabolic syndrome in a metapopulation of Croatian island isolates.

Authors:  Ivana Kolcić; Ariana Vorko-Jović; Branka Salzer; Mladen Smoljanović; Josipa Kern; Silvije Vuletić
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

8.  Non alcoholic fatty liver disease and metabolic syndrome.

Authors:  P Paschos; K Paletas
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471

9.  Prevalence of metabolic syndrome in Galicia (NW Spain) on four alternative definitions and association with insulin resistance.

Authors:  M A Tomé; M A Botana; C Cadarso-Suárez; A Rego-Iraeta; A Fernández-Mariño; J A Mato; I Solache; R Perez-Fernandez
Journal:  J Endocrinol Invest       Date:  2009-03-24       Impact factor: 4.256

10.  Implementation of guidelines for the management of arterial hypertension. The impulsion study.

Authors:  Asterios Karagiannis; Apostolos I Hatzitolios; Vasilios G Athyros; Kalliopi Deligianni; Charalambos Charalambous; Christos Papathanakis; Georgios Theodosiou; Theodoros Drakidis; Veronika Chatzikaloudi; Chysanthi Kamilali; Sotirios Matsiras; Athanasios Matziris; Christos Savopoulos; Maria Baltatzi; Jobst Rudolf; Konstantinos Tziomalos; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.